C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 513/04 (2006.01) A61K 31/429 (2006.01)
Patent
CA 2561157
The present invention provides compounds of the formula (I) which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
L'invention concerne des composés de formule (I) étant des activateurs de l'activité de glucokinase et pouvant par conséquent être employés en tant qu'agents thérapeutiques destinés au traitement de troubles à médiation par glucokinase. Lesdits composés de formule (I) peuvent être employés dans la prévention et le traitement de l'intolérance au glucose, du diabète de type 2 et de l'obésité.
Bebernitz Gregory Raymond
Gupta Ramesh Chandra
Jagtap Vikrant Vijaykumar
Mandhare Appaji Baburao
Tuli Davinder
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Thiazolopyridine derivatives, pharmaceutical conditions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolopyridine derivatives, pharmaceutical conditions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolopyridine derivatives, pharmaceutical conditions... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1648614